Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle S Smith

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Cancer Research|November 5, 2025
The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from PatientsKarishma Gangwani, Congyu Lu, Sandeep Kumar Dhanda, et al.
Neuro-Oncology|January 9, 2020
SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumorsPooja Panwalkar, Drew Pratt, Chan Chung, et al.
Neuro-Oncology|December 22, 2021
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)Sarah E S Leary, Lindsay Kilburn, J Russell Geyer, et al.
Acta Neuropathologica|June 11, 2020
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resourceKyle S Smith, Ke Xu, Kimberly S Mercer, et al.
JAMA Oncology|July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology GroupSarah E S Leary, Roger J Packer, Yimei Li, et al.
Neuro-Oncology|October 29, 2025
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survivalAuthors Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, et al.
Nature Communications|May 26, 2022
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapyJennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Nature Communications|December 22, 2019
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapyJennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Genes & Development|August 22, 2020
Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formationLena M Kutscher, Konstantin Okonechnikov, Nadja V Batora, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Cancer Research|November 5, 2025
The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from PatientsKarishma Gangwani, Congyu Lu, Sandeep Kumar Dhanda, et al.
Neuro-Oncology|January 9, 2020
SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumorsPooja Panwalkar, Drew Pratt, Chan Chung, et al.
Neuro-Oncology|December 22, 2021
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)Sarah E S Leary, Lindsay Kilburn, J Russell Geyer, et al.
Acta Neuropathologica|June 11, 2020
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resourceKyle S Smith, Ke Xu, Kimberly S Mercer, et al.
JAMA Oncology|July 22, 2021
Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology GroupSarah E S Leary, Roger J Packer, Yimei Li, et al.
Neuro-Oncology|October 29, 2025
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survivalAuthors Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, et al.
Nature Communications|May 26, 2022
Author Correction: scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapyJennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Nature Communications|December 22, 2019
scRNA-seq in medulloblastoma shows cellular heterogeneity and lineage expansion support resistance to SHH inhibitor therapyJennifer Karin Ocasio, Benjamin Babcock, Daniel Malawsky, et al.
Genes & Development|August 22, 2020
Functional loss of a noncanonical BCOR-PRC1.1 complex accelerates SHH-driven medulloblastoma formationLena M Kutscher, Konstantin Okonechnikov, Nadja V Batora, et al.
Pageof 8